Loss of taste and smell during treatment with topiramate

  • A. Ghanizadeh
Case Report


Topiramate has already been suggested for treatment of olfactory hallucianation. This is a report of a three and a half-year-old boy with idiopathic generalized tonic colonic epilepsy. He had lost his ability to detect and recognize taste and odor during treatment with topiramate. Those abilities improved after discontinuation of topiramate.

Key words

Topiramate taste smell sensory epilepsy 


  1. 1.
    Wu W.N., Heebner J.B., Streeter A.J., Moyer M.D., Takacs A.R., Doose R.D. Ferraiolo B.L.: Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant, topiramate in healthy men. Pharm. Res., 11, Suppl., S336, 1994.Google Scholar
  2. 2.
    Faught E., Wilder B.J., Ramsay R.E., Reife R.A., Kramer L.D., Pledger G.W.: Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology, 46, 1684–1690, 1996.Google Scholar
  3. 3.
    Langtry H.D., Gillis J.C., Davis R.: Topiramate — a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs, 54, 752–972, 1997.PubMedCrossRefGoogle Scholar
  4. 4.
    Van Ameringen M., Mancini C., Pipe B., Campbell M., Oakman J.: Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J. Clin. Psychiatry, 63, 981–984, 2002.PubMedCrossRefGoogle Scholar
  5. 5.
    Dursun S.M., Devarajan S.: Clozapine weight gain, plus topiramate weight loss [letter]. Can. J. Psychiatry, 45, 198, 2000.PubMedGoogle Scholar
  6. 6.
    Johnson J., Bourgeois J.A., Quanbeck C.: Treatment of olfactory hallucinations with topiramate. J. Clin. Psychopharmacol., 26, 340–341, 2006.PubMedCrossRefGoogle Scholar
  7. 7.
    Anghelescu I., Klawe C., Himmerich H., Szegedi A.: Topiramate in venlafaxine-induced visual hallucinations in an obese patient with a posterior cerebral artery infarction. J. Clin. Psychopharmacol., 21, 462–464, 2001.PubMedCrossRefGoogle Scholar
  8. 8.
    Siniscalchi A., Gallelli L., Marigliano N.M., Orlando P., De Sarro G.: Use of topiramate for glossodynia. Pain Med., 8, 531–534, 2007.PubMedCrossRefGoogle Scholar

Copyright information

© Editrice Kurtis 2009

Authors and Affiliations

  1. 1.Research Center for Psychiatry and Behavioral SciencesShiraz University of Medical Sciences, Hafez HospitalShirazIran
  2. 2.The Academic Child Psychiatry Unit, Department of Paediatrics, Royal Children’s HospitalThe University of MelbourneMelbourneAustralia

Personalised recommendations